Pharmaceutical Lipids Market Size, Share & Trend Analysis, By Product, By Chemical Source, By Source, By Composition, By Application, By Route of Administration, Regional Stance, Competitive Tactics, and Segment Forecast to 2030

Pharmaceutical Lipids Market Overview

The report is titled as ‘Pharmaceutical Lipids Market: Opportunity Analysis and Future Assessment 2022-2030’. An overview of conceptual frameworks, analytical approaches of the Pharmaceutical Lipids market is the main objective of the report, which further consists the market opportunity and insights of the data involved in the making of the respective market.

The pharmaceutical lipids market is estimated to reach at a value of US$ 5,740.4 Mn by the end of 2022 and expected to reach at a value of US$ 10,306.1 Mn by 2030 with a significant CAGR of 7.6%.

Pharmaceutical Lipids Overview

Lipids can be understood as organic compounds that comprise carbon, hydrogen, and oxygen atoms, which makes the composition for the design and function of living cells. These organic compounds are basically nonpolar molecules, which can get dissolved only in nonpolar solvents and are insoluble in water as water is a polar molecule. In the human body, these molecules can be synthesized in the liver and are found in butter, oil, cheese, whole milk, fried foods as well as in certain red meats. In the pharmaceutical industry, polymers and lipids are believed as pillar excipients for the composition of different drugs. For instance, the pharmaceutical lipids are employed as solubilizers, stabilizers, transfection agents, permeation enhancers, and many more.

Notably, the pharmaceutical lipids have brief toxicity and have the potential to achieve an enormous fusion of action that paves its way to improved drug delivery. Owing to which, the pharmaceutical lipids witness huge demand all across the global markets and thus estimating rapid market growth in the following years.

In addition to that, the soaring applications of pharmaceutical lipids in various chronic health issues including neurological diseases, cancer, cardiovascular diseases, and other serious ailments is further projected to offer major breakthroughs to the growth of the global pharmaceutical lipids market over the coming years.

Key Takeaways from the Market Study

• The pharmaceutical lipids market is estimated to reach at a value of US$ 5,740.4 Mn by the end of 2022 and expected to reach at a value of US$ 10,306.1 Mn by 2030 with a significant CAGR of 7.6%.
• The simple lipids product type segment in pharmaceutical lipids market is expected to create an incremental opportunity of US$ 2,832.5 Mn during the forecast period
• In 2022, the compound lipid chemical source segment accounted for the largest market share and expected to grow at 7.7% CAGR during the forecast period.
• In 2022, conventional lipid-based drug delivery systems application segment accounted for a key market share and expected to grow at 7.5% CAGR during the forecast period.
• North America region is expected to remain one of the key market throughout the forecast period (2022-2030) and is further anticipated to witness a significant growth in the pharmaceutical industry.
• In terms of value, parental route of administration segment is expected to account more than one third of the market share in 2022

Significant growth in the demand for medicine to alter the growth outlook

Presently, medicine demand is increasing all over the globe, due to growing number of oncological diseases, chronic diseases, and growing awareness for well-being and OTC medicines. Further increase in the incidences for several diseases results in higher demand for medicine intake. The economic and social value of treatments and medications for chronic disease will rise as the prevalence for chronic disease like diabetes is growing, and the pharmaceutical companies are also focusing on volume sales of such medicine and in developing countries these medicines are available at lower prices to reach out maximum customers. Global significant demand for the medicine is fuelling up the consumption for pharmaceutical lipids including liposomal drugs such as for cancer treatment, it is projected that drug manufacturing companies will need to increase their production capacities. Pharmaceutical excipients are expected to aid pharmaceutical lipids achieve better functionalities like longer self-life and also render competitive advantage in formulations.

Pharmaceutical Lipids Market Segmentation

The global pharmaceutical lipids market is segmented on the basis of product, chemical sources, sources, composition, application, route of administration, and region.

By Product

Simple Lipids

Triglycerides

Waxes

Compound Lipids

Phospholipids

Sphignolipids

Glycolipds

Supholipds

Derived Lipids

Steroids

Sterol sulfates

Prostaglandins

Others

Cholesterol

Fatty Acids

Others

By Chemical Sources

Compound Lipids

1,2-Dimyristoyl-sn-glycero-3-phosphate (DMPA)

1,2-Dipalmitoyl-sn-glycero-3-phosphate (DPPA)

1,2-Distearoyl-sn-glycero-3-phosphate (DSPA)

1,2-Dimyristoyl-sn-glycero-3-phosphoglycerol (DMPG)

1,2-Dipalmitoyl-sn-glycero-3-phosphoglycerol (DPPG)

1,2-Distearoyl-sn-glycero-3-phosphoglycerol (DSPG)

1,Palmitoyl-2-oleoyl-sn-glycero-3-phosphoglycerol (POPG)

Others

Derived Lipids

Carotenoids

Retinol

Tocopherols

PGA2

PGB2

PGE2

PGF1α

Others

Others

By Source

Synthetic

Semi-Synthetic

Natural

By Composition

Simple Lipids

Compound Lipids

Derived Lipids

By Application

Conventional Lipid-based Drug Delivery Systems

Self-Emulsifying Drug Delivery Systems

Self-Microemulsifying Drug Delivery Systems

Liposomes

Solid Lipid Nanoparticles

Nanostructured Lipid Carriers

Others

By Route of Administration

Oral

Tablet

Solution

Parenteral

Intravenous

Intramuscular (Vaccines)

Topical

By Region

North America

Latin America

Europe

Asia Pacific

Middle East

Africa

Pharmaceutical Lipids Market Key Players

Some of the key participating players in global pharmaceutical lipids market are:

ABITEC Corporation (ABF Ingredients)

BASF SE

Croda International Plc

CordenPharma

NOF (Nippon Oil & Fats) Corporation

Cayman Chemical Company

Lipoid GmbH

Nippon Fine Chemical Co. Ltd.

Dishman Group

Gattefossé

IOI Oleo GmbH

Stepan Company

Evonik Industries AG

Factors that are benchmarked while estimating the market

Various factors that are benchmarked while estimating the market growth includes (but not restricted to):

Global Economic Growth Outlook

Healthcare Infrastructure Sector Growth Outlook

Top Companies Historical Growth Rate

Impact of Pricing

Growing Demand for Medicine

Growing Investment in Research and Development

Biotechnology industry growth outlook

New Drug Class Development

Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.

A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment like wherein one/two manufacturer(s) dominates the market, it’s product sales, previous growth rates and market expansion plans are considered to generate market share in the market.